Research Use Only: This product is supplied for laboratory research and in-vitro studies. Not for human or veterinary administration.
Ipamorelin
Ipamorelinis a synthetic pentapeptide growth hormone secretagogue that selectively binds the growth hormone secretagogue receptor (GHS-R1a), also known as the ghrelin receptor. In experimental models, Ipamorelin activates Gq/PLC-dependent calcium signaling pathways that stimulate growth hormone release while demonstrating minimal activity on other pituitary hormones, including ACTH, prolactin, FSH, LH, TSH, and cortisol. Due to its high receptor selectivity, Ipamorelin is widely utilized in rese
- Mechanistic pathway studies
- In vitro receptor profiling
- HPLC verified identity and purity
Ships same-day if ordered before 2PM EST
Research Overview
Ipamorelin is a synthetic pentapeptide commonly used as a selective ligand for the growth hormone secretagogue receptor (GHSR-1a) in laboratory research. In controlled experimental settings, ipamorelin is applied as a molecular probe to investigate ghrelin-receptor pharmacology, ligand selectivity, and downstream intracellular signaling cascades associated with G protein–coupled receptor (GPCR) activation.
Compared with less selective secretagogue peptides, ipamorelin has been utilized in preclinical models to support structure–activity relationship (SAR) studies and to help isolate GHSR-linked signaling from broader, multi-receptor secretagogue activity in vitro and in vivo animal systems.
Primary Research Applications
Preclinical Research Summary
Glucocorticoid-Associated Signaling Models
Rodent studies have evaluated ipamorelin in experimental systems modeling glucocorticoid-associated alterations in bone, muscle, and nitrogen metabolism. Reported endpoints include osteoblastic activity markers, bone formation indices, and nitrogen-balance–related measurements under controlled laboratory conditions[2], [3], [4].
Pancreatic Islet and Metabolic Signaling
In isolated pancreas preparations and diabetic rodent models, ipamorelin has been investigated for effects on insulin-release–associated mechanisms, including experimental observations related to calcium-dependent signaling in pancreatic islet cells within defined study designs[5].
Gastrointestinal Motility Models
Preclinical rodent models of postoperative ileus have been used to examine ghrelin-mimetic signaling on gastrointestinal motility. These studies assess parameters such as gastric emptying and intestinal transit distribution using radiolabeled markers to support mechanistic exploration of enteric signaling pathways[7].
Source: PubMed
Molecular Imaging Probe Development
Due to receptor selectivity and synthetic accessibility, ipamorelin has been explored as a scaffold for peptidomimetic derivatives in molecular imaging research. In-vitro feasibility studies have evaluated radiolabeled analogues for ghrelin receptor visualization to support experimental imaging system development[8].
This product is intended exclusively for in vitro laboratory research by qualified professionals. Not for human consumption. Not approved by the FDA.
Published Research Briefs
Our research team has published evidence-checked briefs covering the science behind this compound. Each brief reviews primary sources and grades claims independently.